Based on this law, the Iranian Legal Medicine Organization has adopted procedures in recent years for authorizing legal abortion, which require at least one of a list of 51 conditions to be met for a licence to be issued; 22 relate to the health of the mother and 29 to the health of the fetus. These 51 conditions are serious and incurable diseases that will cause the mother, the fetus or the future child to suffer (6,8,9). The Supreme Leader of Iran, Ayatollah Khamenei, issued a fatwa on this matter in 2003, stating that, "if the fetal condition can be definitively

Objectives: Unsafe abortion is one of the most important causes of death and disability among mothers in countries where abortion is illegal. These conditions have changed since then. The present study has investigated the cases who were referred to the legal medicine organization to receive abortion permission. This country level secondary patient data analysis, investigated all the cases who were referred to the legal medicine centers of Iran for abortion permission during 2015 to 2017. Results: From 21,477 applicants, 15,617 (72.71%) received permission including 14,367 (91.99%) for fetal abnormalities and 1250 (8.01%) for maternal diseases. The most common fetal abnormalities/disorders were nervous system malformations (26.4%), chromosomal abnormalities (18.4%) and of maternal diseases were circulatory system diseases (43.9%), neoplasms (13.4%) and genitourinary system diseases (9.9%). The most common reasons for not permission were lack of supplementary documents to prove (38.8%), not competency with the criteria (33.9%), and gestational age of more than 19 weeks (25.8%).

We decided to conduct a study to determine the prevalence of visual impairment, blindness, refractive errors, and other visual functions in nursing homes of Iran. In this cross-sectional study, 133 elderly persons were selected from seven nursing homes using proportional-to-size random sampling. A Snellen chart was used to measure visual acuity (VA). Refraction was measured in all participants using autorefractometry and retinoscopy. A cover test was applied to assess ocular deviation. Stereopsis, color vision, and contrast sensitivity were evaluated with distance glasses. The prevalence (95% confidence interval [CI]) of visual impairment (VI) (<20/60), low vision (<20/60 to <20/400), and blindness (⩽20/400) was 41.88% (32.81–50.95), 32.48% (23.87–41.09), and 9.40% (4.03–14.77), respectively, based on best-corrected visual acuity (BCVA). The prevalence of myopia (spherical equivalent (SE) < −0.5 D), hyperopia (SE < 0.5 D), and astigmatism (cylindrical power < 0.5 D) was 53.50% (44.19–62.58), 36.84% (28.38–46.19), and 86.84% (79.17–91.97), respectively. VI and refractive errors had no association with age and sex ( p-value > .05 for all). The prevalence of other ocular diseases was as follows: cataract 66.06% (57.02–75.09), glaucoma 1.52% (1.85–5.40), one eyed caused by injury 6.10% (2.67–11.67), and corneal opacity 3.81% (1.25–8.68). The prevalence of VI was 4–20 times and the prevalence of cataract was 3–4 times higher in NHRs compared with community-dwelling older people, indicating the grave situation of vision in these people. It is necessary to conduct further studies to find the reasons behind this disparity and perform interventions, including periodic and screening examinations upon entry to nursing homes to decrease the burden of ocular diseases in NHRs.

Background:To compare the umbilical cord diameter (UCD) at early second trimester (at 17–19 weeks of gestation) in trisomy 21 and normal fetuses and determined value of measuring UCD in screening trisomy 21.Methods:This was a case–control study. The UCD was measured in 39 fetuses with trisomy 21 (documented by chorionic villus sampling or amniocentesis) and 39 fetuses in control group at 17–19 weeks of gestation. The control groups were low-risk fetuses for aneuploidy in routine screening and were shown not to have aneuploidy after birth.Results:Mean of UCD in fetuses with trisomy 21 was lower than normal fetuses, but there were no significant differences between them (7.48 ± 0.99 mm vs. 7.66 ± 0.91 mm; P = 0.41). Mean of UCD had no significant difference between other maternal variable, for example, body mass index and obstetric history. Mean of UCD among mothers who had previous cesarean section was significantly lower than without it (7.21 ± 0.97 vs. 7.71 ± 0.97; P = 0.03).Conclusions:At 17–19 weeks of gestation, the UCD of fetuses with trisomy 21 is thinner than normal, but the importance of this difference is too small for using this measurement in screening.